BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23790742)

  • 1. Long-acting injectable depot naltrexone use in the Veterans' Health Administration: a national study.
    Marienfeld C; Iheanacho T; Issa M; Rosenheck RA
    Addict Behav; 2014 Feb; 39(2):434-8. PubMed ID: 23790742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study.
    Iheanacho T; Issa M; Marienfeld C; Rosenheck R
    Drug Alcohol Depend; 2013 Sep; 132(1-2):122-6. PubMed ID: 23434041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric services and prescription fills among veterans with serious mental illness in methadone maintenance treatment.
    Marienfeld C; Rosenheck RA
    J Dual Diagn; 2015; 11(2):128-35. PubMed ID: 25781867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration.
    Kelly MM; Reilly E; QuiƱones T; Desai N; Rosenheck R
    Drug Alcohol Depend; 2018 Feb; 183():111-117. PubMed ID: 29245103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses.
    Rubinsky AD; Chen C; Batki SL; Williams EC; Harris AH
    J Psychiatr Res; 2015 Oct; 69():150-7. PubMed ID: 26343607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTSD and substance use disorder among veterans: characteristics, service utilization and pharmacotherapy.
    Bowe A; Rosenheck R
    J Dual Diagn; 2015; 11(1):22-32. PubMed ID: 25513763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems.
    Timko C; Dixon K; Moos RH
    Ment Health Serv Res; 2005 Dec; 7(4):229-42. PubMed ID: 16320106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended release naltrexone for alcohol use disorders: quasi-experimental effects on mortality and subsequent detoxification episodes.
    Harris AH; Bowe T; Del Re AC; Finlay AK; Oliva E; Myrick HL; Rubinsky AD
    Alcohol Clin Exp Res; 2015 Jan; 39(1):79-83. PubMed ID: 25623408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in veterans health administration mental health service use: effects of age and psychiatric diagnosis.
    Chatterjee S; Rath ME; Spiro A; Eisen S; Sloan KL; Rosen AK
    Womens Health Issues; 2009; 19(3):176-84. PubMed ID: 19447322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental health service use: comparing people who served in the military or received Veterans' Affairs benefits and the general population.
    McGuire A; Dobson A; Mewton L; Varker T; Forbes D; Wade D
    Aust N Z J Public Health; 2015 Dec; 39(6):524-9. PubMed ID: 26337053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of mental health services by women in a male-dominated environment: the VA experience.
    Hoff RA; Rosenheck RA
    Psychiatr Serv; 1997 Nov; 48(11):1408-14. PubMed ID: 9355167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence.
    Harris AH; Oliva E; Bowe T; Humphreys KN; Kivlahan DR; Trafton JA
    Psychiatr Serv; 2012 Jul; 63(7):679-85. PubMed ID: 22549276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of demographic differences on native veterans' outpatient service utilization.
    Brooks E; Kaufman C; Nagamoto HT; Dailey NK; Bair BD; Shore J
    Psychol Serv; 2015 May; 12(2):134-40. PubMed ID: 25961649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in veterans with alcohol dependence and co-occurring mental illness.
    Ralevski E; Gianoli MO; McCarthy E; Petrakis I
    Addict Behav; 2014 Feb; 39(2):386-91. PubMed ID: 23890764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use Disorder.
    Muvvala SB; O'Malley SS; Rosenheck R
    Am J Addict; 2021 Jan; 30(1):55-64. PubMed ID: 32805083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs.
    Petrakis IL; Leslie D; Rosenheck R
    Alcohol Clin Exp Res; 2003 Nov; 27(11):1780-4. PubMed ID: 14634494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of nursing home admission in association with mental illness nationally in the Department of Veterans Affairs.
    Miller EA; Rosenheck RA
    Med Care; 2006 Apr; 44(4):343-51. PubMed ID: 16565635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance Use Disorder Among Current Cancer Patients: Rates and Correlates Nationally in the Department of Veterans Affairs.
    Ho P; Rosenheck R
    Psychosomatics; 2018; 59(3):267-276. PubMed ID: 29452704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, pharmacotherapy and clinical correlates of diagnosed insomnia among Veterans Health Administration service users nationally.
    Hermes E; Rosenheck R
    Sleep Med; 2014 May; 15(5):508-14. PubMed ID: 24767725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of health services use following the initiation of risperidone long-acting therapy among schizophrenia patients in the veterans health administration.
    Ren XS; Crivera C; Sikirica M; Dirani R; Qian S; Kazis LE
    J Clin Pharm Ther; 2011 Jun; 36(3):383-9. PubMed ID: 21062329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.